|
Dec 28
|
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs Healthcare C-Suite Unscripted Conference
|
|
Dec 18
|
Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks
|
|
Dec 5
|
Nike assumed at Buy, 'near-term challenges well understood': 4 big analyst picks
|
|
Dec 4
|
Apellis (APLS) Rides on Syfovre to Fuel Growth Amid Rivalry
|
|
Dec 1
|
Apellis Pharmaceuticals, Inc. (APLS) Up 9.2% Since Last Earnings Report: Can It Continue?
|
|
Nov 30
|
Apellis Pharmaceuticals' (NASDAQ:APLS) growing losses don't faze investors as the stock rises 5.6% this past week
|
|
Sep 12
|
Insider Sell: Pascal Deschatelets Sells 12,000 Shares of Apellis Pharmaceuticals Inc
|
|
Sep 7
|
Bluebird (BLUE) Up 7.3% Since Last Earnings Report: Can It Continue?
|
|
Sep 6
|
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Sep 6
|
Investing in Apellis Pharmaceuticals (APLS): Navigating the Thin Line Between Value and Trap
|
|
Sep 6
|
Apellis' Waltham office to lose 175 in layoffs
|
|
May 3
|
Apellis Pharmaceuticals to Present at the Bank of America Securities 2023 Healthcare Conference
|
|
May 1
|
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
|
|
Apr 27
|
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 27
|
Apellis Pharmaceuticals to Host Conference Call on May 4, 2023, to Discuss First Quarter 2023 Financial Results
|